1. Home
  2. DRVN vs NVAX Comparison

DRVN vs NVAX Comparison

Compare DRVN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$10.70

Market Cap

1.7B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$10.10

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
NVAX
Founded
1972
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
DRVN
NVAX
Price
$10.70
$10.10
Analyst Decision
Buy
Hold
Analyst Count
8
9
Target Price
$19.57
$11.33
AVG Volume (30 Days)
2.3M
4.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
59.82
309.76
EPS
0.69
2.58
Revenue
$2,339,588,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.10
N/A
P/E Ratio
$15.35
$3.89
Revenue Growth
1.54
64.69
52 Week Low
$9.80
$5.01
52 Week High
$19.74
$11.85

Technical Indicators

Market Signals
Indicator
DRVN
NVAX
Relative Strength Index (RSI) 26.64 52.87
Support Level $9.92 $7.81
Resistance Level $15.81 $10.63
Average True Range (ATR) 0.46 0.66
MACD 0.02 -0.05
Stochastic Oscillator 40.95 44.95

Price Performance

Historical Comparison
DRVN
NVAX

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: